ReviewFrontiers in pharmacology2024

Antibody-drug conjugates targeting HER2 for the treatment of urothelial carcinoma: potential therapies for HER2-positive urothelial carcinoma.

Chia-Hsien Shih et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.